Working for you and your patients
Purchasing health products from Amazon, Groupon and various Social Media outlets has become the norm, and all with one common theme stated on the label “this product is not intended to diagnose or treat disease, or to substitute for a physician's consultation.” Never truly knowing what they purchased, nor, what was actually “in the bottle,” many consumers end up disappointed with a product’s effects and outcomes. In some cases even worse outcomes occur i.e. “Utah officials warn of phony CBD oil that causes seizures, loss of consciousness and slurred speech.”
Patients are looking for non-synthetic and non-addictive alternatives for the treatment of many conditions. They are turning to healthcare providers for guidance but there is little credible information being shared in a scientific way with healthcare providers.
The Healthcare Provider
The FDA and Healthcare Providers are seeking legitimate research data on CBD and other non-addictive treatment alternatives. There remains many unanswered questions about CBD products outside the approved drug context. For example, there are open questions such as:
How much CBD is safe to consume in a day? How does it vary depending on what form it’s taken?
Are there drug interactions that need to be monitored?
What are the impacts to special populations, like children, the elderly, and pregnant or lactating women?
What are the risks of long-term exposure?
Additionally, there is a lack of information on dosage and administration information and credentialed product sources.
Only 13% of medical schools have education on the endocannabinoid system. Physicians in the CCS network have access to accredited education on the endocannabinoid system and will continue receiving the most current findings through our educational portal that will keep them up to date on the latest research and best practices for CBD usage.
Ready to Join the Research Affiliate Program?
We'll send you everything you need to get your practice up and running.